Showing 34,781 results

Hepatitis C treatment

Young adults with vertical HIV and hepatitis C co-infection have a high hepatitis C cure rate

News
2 August 2019
Conference announcements & declarations

Really Rapid Review — IAS 2019 Mexico City

Editor's pick
NEJM Journal Watch
2 August 2019
Women

Daring to dream: the women and girls on HIV's new front line

Editor's pick
The Telegraph
2 August 2019
Epidemiology

HIV-Related Deaths on the Rise in Russia

Editor's pick
The Moscow Times
2 August 2019
Conference announcements & declarations

Reflections from IAS 2019: Policies to End the HIV/AIDS Epidemic

Editor's pick
Friends of the Global Fight
2 August 2019
Changing treatment

High efficacy from switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance

Editor's pick
i-Base
2 August 2019
The search for a cure

The State of Cure Research for HIV and Hepatitis B: Similarities and Differences

Editor's pick
TheBodyPro
2 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019
Cancer

HIV infection worsens cancer outcomes among elderly

Editor's pick
Healio
2 August 2019
Retention & linkage to care

Having Fallen Out of Care, Most Gay and Bisexual Men With Detectable HIV Viral Loads Were Successfully Reconnected, Study Finds

Editor's pick
TheBodyPro
1 August 2019
Hepatitis & HIV

13% of HIV-positive Europeans who are cured of hepatitis C are reinfected

News
31 July 2019
How HIV works

Could a better understanding of inflammation help research towards an HIV cure?

News
31 July 2019

Wednesday 31st July 2019

July 2019

Quarta-feira 31 de julho de 2019

July 2019

Mercredi 31 juillet 2019

July 2019

Среда, 31 июля 2019 года

July 2019

Miércoles, 31 de julio de 2019

July 2019

Mercoledì 31 luglio 2019

July 2019
PrEP programmes & uptake

Same-day initiation of PrEP feasible and safe in Latin America

News
30 July 2019
Access to healthcare

Five years on, 3.9 million people in the developing world have access to HIV treatment dolutegravir, thanks to access-oriented voluntary licensing agreements

Editor's pick
Medicines Patent Pool
30 July 2019
HIV & criminal law

Getting to zero? HIV criminalization and treatment adherence surveillance

Editor's pick
CATIE Blog
30 July 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits regulatory application to EMA for the first monthly, injectable treatment for HIV

Editor's pick
ViiV press release
30 July 2019
People with limited treatment options

EMA panel recommends ibalizumab for multidrug-resistant HIV-1

Editor's pick
Medscape (requires free registration)
30 July 2019
HIV treatment for children & young people

Without frequent viral load monitoring dolutegravir-based regimens not the best choice for African youth on failing ART

News
30 July 2019